Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H44O2 |
Molecular Weight | 400.6371 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C
InChI
InChIKey=YIKKMWSQVKJCOP-ABXCMAEBSA-N
InChI=1S/C27H44O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-23,25,28H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,25+,26+,27-/m1/s1
7-Oxocholesterol (7-Ketocholesterol) is a major oxidation product of cholesterol (oxysterol) found in human atherosclerotic plaque and is more atherogenic than cholesterol in some animal studies. Oxysterols (oxygenated forms of cholesterol) are present at low levels in the circulation and accumulate is plasma and tissues in some pathologies. In atherosclerotic lesions, 7-oxygenated oxysterols, predominantly 7-ketocholesterol, accumulate and have been implicated in the pathology of the disease. There is some in vivo and in vitro evidence that sterol 27-hydroxylase acts on 7-ketocholesterol to initiate its degradation to more polar, water-soluble products. Recent studies indicate an alternative mechanism, in which 7-ketocholesterol is reduced to 7 beta-hydroxycholesterol by 11 beta-hydroxysteroid dehydrogenase type 1. 7-Ketocholesterol can inhibit cholesterol 7 alpha-hydroxylase, the rate-limiting step in bile acid biosynthesis, as well as strongly inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. It has even been suggested that 7-ketocholesterol is formed enzymically as an endogenous regulator of cholesterol biosynthesis. However, when tested as a pharmacological cholesterol-lowering agent, inhibition of HMG-CoA reductase was rapidly overcome and the 7-ketocholesterol metabolised. In vitro, 7-ketocholesterol has wide-ranging and potent effects, most of which have the potential to contribute to atherosclerosis. For example, 7-ketocholesterol can be cytotoxic and can induce apoptosis in vascular cells. These effects, either individually or more likely, in combination, all implicate 7-ketocholesterol in the initiation and development of atherosclerosis, but further work is needed to establish whether or not its role is a direct causal one. 7-Ketocholesterol is the second most abundant oxysterol found in human atherosclerotic plaque, after the enzymically formed 27-hydroxycholesterol (cholest-5-ene-3beta,27-diol). 7-Ketocholesterol differs from cholesterol by a ketone functional group present at the 7-position. It is produced from cholesterol via the epimeric cholesterol 7-hydroperoxides (cholest-5-ene-3beta-ol-7-hydroperoxide) which decompose to the epimeric 7-hydroxycholesterols (cholest-5-ene-3beta,7-diol) and 7-ketocholesterol. 7-Ketocholesterol is a major dietary oxysterol. It has also been widely suggested that 7-ketocholesterol present in atherosclerotic tissue may be derived from the diet. Certainly, 7-ketocholesterol is a major oxysterol found in cholesterol-rich processed foodstuffs. Dietary 7-ketocholesterol is rapidly metabolised by the liver to 7beta-hydroxycholesterol (cholest-5-ene-3beta,7beta-diol), unusual bile acids and perhaps even cholesterol itself. Its conversion to 7beta-hydroxycholesterol is well documented.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P22680 Gene ID: 1581.0 Gene Symbol: CYP7A1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/10224662 |
|||
Target ID: CHEMBL402 |
|||
Target ID: CHEMBL3201 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22304296 |
7.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Concentration of the oxygenated derivates of cholesterol in pregnant women suffering from diabetes type I]. | 2002 |
|
Oxysterol-induced apoptosis of vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitor, pravastatin. | 2002 |
|
Oxidized lipoproteins and macrophages. | 2002 Apr |
|
Flow cytometry and factor analysis evaluation of confocal image sequences of morphologic and functional changes occurring at the mitochondrial level during 7-ketocholesterol-induced cell death. | 2002 Dec |
|
Alpha-tocopherol prevents apoptosis of vascular endothelial cells via a mechanism exceeding that of mere antioxidation. | 2002 Dec 5 |
|
Nitric oxide, cholesterol oxides and endothelium-dependent vasodilation in plasma of patients with essential hypertension. | 2002 Nov |
|
The impairment of endothelium-dependent arterial relaxation by 7-ketocholesterol is associated with an early activation of protein kinase C. | 2002 Nov |
|
7-ketocholesterol in human and adapted milk formulas. | 2002 Oct |
|
Dietary cholesterol-oxidation products accumulate in serum and liver in apolipoprotein E-deficient mice, but do not accelerate atherosclerosis. | 2002 Oct |
|
Cholesterol oxides, cholesterol, total lipid, and fatty acid composition in turkey meat. | 2002 Oct 9 |
|
Protection of superoxide-induced cholesterol oxidation by antioxidants in protic conditions. | 2002 Sep |
|
Chronology of cellular alterations during 7-ketocholesterol-induced cell death on A7R5 rat smooth muscle cells: analysis by time lapse-video microscopy and conventional fluorescence microscopy. | 2003 Apr |
|
Lipid peroxidation and vitamin E in human coronary atherosclerotic lesions. | 2003 Apr |
|
Impairment of the cytotoxic and oxidative activities of 7 beta-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. | 2003 Apr 11 |
|
Presence of phytosterol oxides in crude vegetable oils and their fate during refining. | 2003 Apr 9 |
|
Cholesterol oxides mediated changes in cytoskeletal organisation involves Rho GTPases. | 2003 Dec 10 |
|
Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines. | 2003 Jan 13 |
|
Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. | 2003 Jan 15 |
|
Increase in cholesterol and cholesterol oxidation products, and role of cholesterol oxidation products in kainate-induced neuronal injury. | 2003 Jul |
|
Consecutive administration of paraquat to rats induces enhanced cholesterol peroxidation and lung injury. | 2003 Jun |
|
Oxysterol-induced toxicity in R28 and ARPE-19 cells. | 2003 Jun |
|
Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis. | 2003 Jun 6 |
|
7-hydroperoxycholesterol and oxysterols as indices of oxidative stress: chronic ethanol feeding and rat skeletal muscle. | 2003 Mar |
|
Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. | 2003 Mar 1 |
|
Cholesterol is superior to 7-ketocholesterol or 7 alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A:cholesterol acyltransferase 1. | 2003 Mar 28 |
|
Lysophosphatidylcholine regulates synthesis of biglycan and the proteoglycan form of macrophage colony stimulating factor. | 2003 May 1 |
|
Origin of oxysterols in hepatic bile of patients with biliary infection. | 2003 Oct |
|
Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. | 2003 Oct 15 |
|
Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture. | 2003 Oct 15 |
|
Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL. | 2003 Oct 17 |
|
7-ketocholesterol stimulates differentiation of lens epithelial cells. | 2003 Oct 6 |
|
Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification. | 2003 Sep |
|
Identification and quantification of cholesterol and cholesterol oxidation products in different types of Iberian hams. | 2003 Sep 10 |
|
Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. | 2004 Apr |
|
Oxysterols regulate expression of the steroidogenic acute regulatory protein. | 2004 Apr |
|
Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. | 2004 Apr |
|
Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. | 2004 Apr 30 |
|
Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. | 2004 Aug |
|
Analysis of the fluorescence of monodansylcadaverine-positive cytoplasmic structures during 7-ketocholesterol-induced cell death. | 2004 Feb |
|
Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function. | 2004 Feb 3 |
|
Trojan horse-like behavior of a biologically representative mixture of oxysterols. | 2004 Feb-Apr |
|
Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. | 2004 Jan |
|
AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. | 2004 Jan 9 |
|
Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase. | 2004 Jul 23 |
|
The leaf extract of Ginkgo Biloba L. suppresses oxidized LDL-stimulated fibronectin production through an antioxidant action in rat mesangial cells. | 2004 Jun |
|
Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. | 2004 Jun 1 |
|
Mechanisms of resistance to the cytotoxic effects of oxysterols in human leukemic cells. | 2004 Mar |
|
Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. | 2004 Mar |
|
Comparison of cholesterol oxidation product preparation methods for subsequent gas chromatographic analysis. | 2004 Mar-Apr |
|
Analysis of cholesterol oxidation products in biological samples. | 2004 Mar-Apr |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17089016
A group of mice was treated with Oxocholesterol (7-Ketocholesterol) subcutaneously for 1 week (10 mg/kg/day).
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17089016
Human umbilical vein endothelial (HUVEC) cells were treated with 2-16 ug/ml 7-Oxocholesterol (7-Ketocholesterol) as well as vascular rings harvested from BALB/c mouse thoracic aorta with 90 ug/ml 7-Oxocholesterol (7-Ketocholesterol) for 2 h.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
92764-0
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
O7676FE78M
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
PRIMARY | |||
|
64294
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
PRIMARY | |||
|
C003001
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
PRIMARY | |||
|
91474
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
PRIMARY | |||
|
566-28-9
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
PRIMARY | |||
|
DTXSID901033744
Created by
admin on Fri Dec 15 19:13:10 GMT 2023 , Edited by admin on Fri Dec 15 19:13:10 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD